+86 16650237703
Author:Kangdi 14-10-2026
Menthol Patch Concentration Chart 2026: 3% to 10% Explained for Pain Relief Buyers
Shopping for a menthol patch and confused by 3%, 5%, 7%, or 10% on the label? This page is a complete concentration-to-effect reference for B2B buyers, clinical procurement teams, and product managers evaluating menthol patches (also labelled cooling patches, cold therapy patches, ice patches, or mentholated topical patches in different markets). The quick answer up front: 3% to 5% menthol is the sweet spot for general OTC pain relief, 7% is for athletic or post-injury recovery, and 10% is prescription-grade or specialised physical therapy use only. Below you will find a full concentration chart, an eight-row comparison table, and the seven formulation variables that determine whether a 5% patch actually delivers a 5% experience or a watered-down 2% feeling.
If you only have 30 seconds, skip to Section 1 for the chart, or Section 6 for the buyer checklist. If you have 15 minutes, read the whole page — it is designed to be the single reference a procurement team prints and keeps next to their RFQ inbox.
Bottom line for B2B buyers. Menthol concentration on a patch label tells you roughly 60% of what you need to know about efficacy; the other 40% is the cooling agent system (menthol-only vs menthol + menthyl lactate vs menthol + camphor blend), the delivery rate (mg per hour across 8 hours vs burst-release in the first 30 minutes), and the matrix thickness. A 5% menthol-only patch on a thin hydrogel matrix typically delivers a noticeably gentler experience than a 5% menthol + methyl salicylate patch on a 1.6 mm adhesive — even though both labels read "5% menthol". Always test by wearing it for 8 hours before signing a 50,000-unit PO.
Table of Contents
- Menthol patch concentration chart at a glance
- What each concentration really feels like (3% to 10%)
- How menthol works: receptor biology in 90 seconds
- Menthol vs methyl salicylate vs camphor vs lidocaine: the cooling-pain family
- Single-ingredient menthol vs menthol blend formulas
- The seven formulation variables that determine real-world efficacy
- Market snapshot: which concentration is dominant in which region in 2026
- Buyer-side FAQs: menthol patch concentration questions most distributors ask
- About Kangdi Medical and how to request a sample shipment
1. Menthol Patch Concentration Chart at a Glance
The chart below summarises how menthol concentration maps to user experience, target market, and typical shelf-life formulation stability. Menthol concentration here refers to the labelled w/w percentage of menthol (l-menthol or racemic menthol) loaded into the adhesive matrix; coolant blend percentages are additional and may reach 12-14% in some professional formulations.
| Concentration range | Typical user experience | Onset time | Duration of cooling effect | Common product positioning | Target buyer profile | Typical regulatory class |
|---|---|---|---|---|---|---|
| 1.5% to 3% | Subtle, gentle cool tingle | 10-15 minutes | 3-5 hours | "Everyday", entry-level OTC, family-friendly | Mass-market consumer, pharmacies, supermarkets | Cosmetic or topical OTC (cosmetic claim in EU) |
| 3% to 5% | Clear cooling sensation; mild analgesic comfort | 5-10 minutes | 5-8 hours | Standard OTC pain patch; chronic back, neck, shoulder | Pharmacy chains, online retail, sports retail | Topical OTC / cosmetic (claim-dependent by market) |
| 5% to 7% | Strong, sustained cool; mild counter-irritant effect | 3-6 minutes | 6-10 hours | Sports recovery, post-workout, post-injury recovery | Sports medicine distributors, athletic-clinic channels | Topical OTC, sometimes quasi-drug (Japan) |
| 7% to 10% | Very strong, almost icy; marked counter-irritant effect | 2-4 minutes | 8-12 hours | Professional sports therapy, occupational recovery | Sports medicine clinics, physiotherapy wholesalers | Quasi-drug (Japan) or topical analgesic (US OTC monograph) |
| 10% to 16% (rare, clinical-use only) | Pharmacy-only; reserved for clinical or prescription use | 1-3 minutes | 10-14 hours | Specialist compounding, hospital pain clinic | Hospital pharmacies, compounding pharmacies | Prescription drug or compounded pharmacy product (US) |
What this chart tells you at a glance: if your distribution channel is general retail or pharmacy chain, the 3% to 5% range covers roughly 70% of consumer demand in 2026 and is where price-per-patch competition is highest. The 5% to 7% range is where margin per unit is healthy and brand differentiation is plausible. Above 10% you have exited the OTC consumer market in most jurisdictions.
2. What Each Concentration Really Feels Like (3% to 10%)
Concentration labels do not translate linearly to perceived sensation. Here is what experienced testers (panel of 24 testers, lab-blinded, 8-hour wear protocol, indoor temperature 22°C) typically report across the concentration range.
- 3% menthol: a soft, breath-freshener-like cooling on the skin; many testers describe it as "comfortable" or "pleasant". Tolerable for the full 8-hour wear; very low perceived intensity. Best suited to first-time patch users, sensitive-skin consumers, daytime wear under clothing.
- 5% menthol: the most consistent perception of "clearly cooling without being intense"; mid-range tingling that testers consistently describe as "this is what a pain patch should feel like". Best for general OTC pain relief, lower-back and shoulder tension, mild arthritis in older consumers.
- 7% menthol: a noticeably stronger cool sensation that engages mild counter-irritant effects; some testers experience a "very cold" feeling within the first 30 minutes. Best for sports recovery, delayed-onset muscle soreness (DOMS), and post-physiotherapy use.
- 10% menthol: an icy, almost peppermint-oil intensity; testers often report running their fingers under cold water after the patch is removed. The cooling effect can interfere with sleep in some users. Reserved for users who know they prefer very strong cooling.
Important: perception depends as much on the matrix thickness, the presence of permeation enhancers (eucalyptol, menthyl lactate, methyl salicylate), and the patch's water activity (how much sweat-induced swelling has been allowed for) as on concentration itself. A 5% menthol patch in a thin, dry matrix feels different from a 5% patch in a 1.4 mm hydrogel that has been pre-conditioned for high humidity markets.
3. How Menthol Works: Receptor Biology in 90 Seconds
Menthol is not a chemical analgesic in the classical sense — it does not block COX enzymes, it does not inhibit prostaglandin synthesis, and it does not interact with opioid pathways. What it does is engage the TRPM8 cold receptor, the same receptor that fires when your skin touches ice water or a menthol-flavoured candy touches your tongue. When TRPM8 is activated, the sensory nerve interprets the signal as cold, which gates competing pain signals at the spinal level (the "gate control" mechanism). The brain receives less pain input because it receives more cooling input.
The cooling sensation you feel is real — a measurable drop in skin temperature of about 1.5-2.5°C over the first 30 minutes in a 5% patch on bare skin. The analgesic effect is downstream of the cooling effect, not independent of it. This is why menthol is sometimes paired with mild chemical analgesics (methyl salicylate, camphor, even low-dose lidocaine) to layer two pain pathways on top of each other.
Practical implication for buyers: a menthol patch with no additional analgesic is well-suited to muscle tension and exercise recovery (where the cause of pain is mechanical and localised). A menthol patch combined with another analgesic is better for arthritis or post-traumatic pain (where inflammation is part of the driver). Choosing between the two is part of building a B2B catalogue that covers more than one pain profile.
4. Menthol vs Methyl Salicylate vs Camphor vs Lidocaine: The Cooling-Pain Family
Menthol is rarely the only active in a pain patch. The chart below compares it to the other common actives in the topical OTC category, so you can decide which fits your product brief.
| Active ingredient | Concentration range in patches | Mechanism | Onset | Sensation | Market status 2026 |
|---|---|---|---|---|---|
| Menthol (l-menthol) | 1.5% to 10%, occasionally 16% in clinical SKUs | TRPM8 cold-receptor agonist | 3-15 minutes | Cooling | Off-patent, unrestricted in most markets |
| Methyl salicylate | 10% to 30% (counter-irritant dose) | Counter-irritant; salicylate COX inhibition | 15-30 minutes | Warming / mild heat | Off-patent; restricted to adult use in some markets (paediatric concerns) |
| Camphor | 3% to 11% | Counter-irritant; mild TRPV1 modulator | 15-30 minutes | Warming / mild heat | Off-patent; FDA OTC monograph allows up to 11% in adult products |
| Lidocaine | 4% to 5% (most OTC); up to 8% prescription-only | Sodium-channel blocker (local anaesthetic) | 5-15 minutes | Numbing / non-cool | Off-patent; OTC monograph 4%-5% as topical anaesthetic; higher doses require prescription |
| Capsaicin | 0.025% to 0.075% (OTC); 0.3% high-strength (Rx) | TRPV1 desensitisation | 30-60 minutes | Burning initially, then numbing | Off-patent; OTC monograph covers 0.025-0.075% range |
| Menthol + methyl salicylate | 3-5% menthol + 10-15% methyl salicylate | Combination: cooling + warming counter-irritant | 5-15 minutes | Cool then warm (layered) | Off-patent; one of the most common dual-active formulations in OTC patches |
| Menthol + lidocaine | 3-7% menthol + 4% lidocaine | Combination: cooling + anaesthetic | 3-10 minutes | Cool, then numb | Off-patent; growing category in US OTC & EU pharma markets |
What this comparison tells you for catalogue planning: a B2B distributor carrying menthol-only, menthol + methyl salicylate, and menthol + lidocaine has full coverage of the cooling-to-warming-to-numbing spectrum within a single regulatory and physical-format family. That is also the lowest-cost SKU portfolio to support, since all three can be made on the same converting line with minimal retooling.
5. Single-Ingredient Menthol vs Menthol Blend Formulas
The single largest efficacy and cost variable in a menthol patch is whether menthol is the only cooling active or whether it is paired with menthyl lactate, methyl salicylate, camphor, or a permeation enhancer. The blend formula almost always lasts longer per wear and feels stronger at the same labelled menthol concentration, but at a cost: the regulatory dossier widens, the skin-irritation testing panel needs to be redone, and the labelling regime gains complexity.
| Formula type | Total cooling-active load | Typical 8-hour efficacy | Skin irritation risk | Regulatory complexity | Cost per patch (2026) |
|---|---|---|---|---|---|
| Menthol-only | 3-5% menthol | Moderate | Low (1-2%) | Lowest — single active, simpler dossier | USD 0.10-0.18 (10x10 cm patch) |
| Menthol + menthyl lactate | 3% menthol + 2-4% menthyl lactate | Moderate-strong (sustained) | Low (1-2%) | Moderate — two actives but both cosmetic-class in EU | USD 0.14-0.22 |
| Menthol + methyl salicylate | 3-5% menthol + 10-15% methyl salicylate | Strong, layered cool-then-warm | Moderate (2-4%) | Higher — methyl salicylate is monitored in some markets for paediatrics | USD 0.16-0.26 |
| Menthol + camphor | 3-5% menthol + 3-5% camphor | Strong, cool-then-warm | Moderate (2-4%) | Higher — camphor has FDA OTC monograph limits to respect | USD 0.15-0.24 |
| Menthol + lidocaine | 3-5% menthol + 4% lidocaine | Strong, cool-then-numb | Moderate (3-5%) | Highest — lidocaine is an OTC monograph drug, requires full drug documentation | USD 0.22-0.34 |
For a B2B catalogue strategy, the practical recommendation is: lead with a 3-5% menthol-only patch for the broad OTC channel, add a menthol + methyl salicylate variant as a higher-margin second SKU, and reserve the menthol + lidocaine patch as a premium third SKU for pharmacy and clinical buyers. That three-SKU structure covers roughly 80% of demand in mature OTC markets without leaving your regulatory team overwhelmed.
6. The Seven Formulation Variables That Determine Real-World Efficacy
Two menthol patches both labelled "5%" can deliver radically different wear experiences. The differences come down to seven formulation and converting-line variables — these are the seven variables every procurement team should be able to discuss with a manufacturer's formulation engineer on a 30-minute supplier qualification call.
>
| # | Formulation variable | Why it matters | What clinical-grade looks like | What commodity stock looks like |
|---|---|---|---|---|
| 1 | Menthol grade (l-menthol vs racemic) | l-menthol has a 2-3x stronger cooling potency than racemic | l-menthol, ≥99% purity, food/pharma grade | Racemic menthol, or partially synthetic racemic blend |
| 2 | Menthol crystal form and particle size | Coarse crystals dissolve slowly and may yield uneven release | Micronised or pre-dissolved menthol in liquid carrier; d90 < 20 μm | As-supplied crystals; visible undissolved patches in storage |
| 3 | Permeation enhancer selection | Enhancers increase skin penetration and cooling onset time | Eucalyptol, menthyl lactate, propylene glycol monolaurate at controlled levels | None, or aggressive DMSO-class enhancers that risk irritation |
| 4 | Matrix polymer and thickness | Thicker matrices sustain release; thin matrices deliver a burst | 1.0-1.6 mm hydrogel or drug-in-adhesive; controlled swell ratio | Generic 0.6 mm wound-dressing matrix; cooling fades by hour 3 |
| 5 | pH of the matrix (final patch) | Below pH 5.0, menthol volatilises; above pH 7.5, menthol partly degrades | Final matrix pH 5.5-6.8 | No pH control; alkalinity accelerates menthol loss |
| 6 | Backing film MVTR | High MVTR (moisture-vapour transmission) means the patch dries and cooling fades | Polyurethane film, MVTR 800-1200 g/m²/day, balanced for sweat resistance | Generic PE film, MVTR <200 g/m²/day, heavy sweating causes premature peel |
| 7 | Primary packaging integrity | Menthol is volatile; leaky seals mean loss of labelled concentration within 6-9 months | Hermetically sealed foil laminate pouch, individual sachet per patch | PE film pouch, multi-pack sachet torn during shipping; visible menthol odour on opening |
How to use this table in practice: ask the supplier for the grade certification on l-menthol (variable 1), the d90 number on its crystals (variable 2), and the MVTR of the backing film (variable 6). If they answer all three with specific numbers in the first conversation, they have a real formulation. If they answer with "high quality", walk on.
7. Market Snapshot: Which Concentration Is Dominant in Which Region in 2026
Regional consumer preferences for menthol concentration differ noticeably in 2026. This is not random — it reflects regulatory history, climate, sports-medicine penetration, and what category-leading local brands launched first. The table below summarises what Kangdi's regional distribution partners report as the dominant concentration range on pharmacy and supermarket shelves in their respective markets.
| Region | Dominant OTC menthol concentration | Most common formulation variant | Distinctive market feature |
|---|---|---|---|
| North America (US, Canada) | 5% to 7% (with some 10% professional lines) | Menthol + methyl salicylate is the dominant dual-active | Strong sports-recovery channel; lidocaine 4% is the main alternative active |
| EU (UK, Germany, France, Italy, Spain) | 3% to 5% | Menthol-only or menthol + menthyl lactate | Most patches registered as cosmetics, not drugs; lighter sensations preferred |
| Japan | 5% to 7% (quasi-drug class) | Menthol + methyl salicylate, menthol + glycol salicylate | Strong PMDA quasi-drug tradition; higher menthol concentrations accepted in adult SKUs |
| South Korea | 5% to 10% | Menthol-only favoured; lidocaine also popular | Strong consumer preference for very strong cooling; 10%+ common in adult-only SKUs |
| Australia & NZ | 3% to 5% | Menthol-only, similar to EU | TGA treats menthol patches as listed medicines; conservative dosing recommended |
| GCC (Saudi, UAE, Kuwait, Qatar) | 5% to 7% | Menthol + methyl salicylate common | Hot climate drives preference for stronger cooling; high menthol melts risk above 30°C warehouse storage |
| LATAM (Brazil, Mexico, Argentina, Chile) | 5% | Menthol + methyl salicylate dominant | Brazil ANVISA has separate cosmetic and drug pathways; menthol-only often registers as cosmetic |
| Southeast Asia (Indonesia, Thailand, Vietnam, Philippines) | 5% to 7% | Menthol + methyl salicylate dominant | Humidity and temperature challenge primary packaging; suppliers must validate stability at 35°C/75% RH |
The pattern: hotter and more humid regions prefer stronger cooling, but the same climate also degrades menthol stability in storage. A 7% menthol patch that loses 30% of its menthol before reaching a consumer in Jakarta is functionally a 5% patch — the labelling is misleading and the efficacy disappoints. This is why primary packaging integrity (variable 7 in the table above) matters more in hot-climate markets than in temperate ones.
8. Buyer-Side FAQs: Menthol Patch Concentration Questions Most Distributors Ask
8.1 Is 10% menthol safe for daily use?
For healthy adults, short-duration daily use (single 8-hour wear, then 16-hour off period) is generally well tolerated, but the same concentration used twice daily over 7-10 days increases skin irritation risk substantially. Above 10%, daily use should be clinically supervised. Children, pregnant women, and people with impaired skin barrier should not use patches above 5% without medical advice.
8.2 Can I sell a menthol patch as a cosmetic in the EU?
Only if the formulation claims are limited to "cooling, soothing, fresh-feeling" and avoid disease or pharmacological claims. As soon as you claim "analgesic", "pain relief", or similar, the product falls under the Medical Device Regulation (MDR) or pharmaceutical classification in most EU member states. Cosmetic menthol patches are typically limited to the 1.5-3% range; medical claims push the product into 3-10% territory and into regulated drug or device territory.
8.3 What is the typical MOQ for a custom-branded menthol patch?
For a Kangdi OEM programme, MOQ starts at 50,000 patches for a stock-matrix menthol patch with custom printing. Pilot runs of 10,000 patches with a longer lead time and a 12-18% price premium are also available. Minimum first PO typically covers 5 SKUs (different sizes and concentration variants) with a total quantity of around 60,000-80,000 patches.
8.4 How is menthol concentration verified on a finished patch?
Two methods are commonly used: (1) gas chromatography (GC) extraction of menthol from the matrix using an organic solvent, with quantification against an external standard; (2) HPLC with refractive-index detection. Acceptable tolerance is ±10% of label claim in a market like the US, FDA-grade OTC monograph products, and ±5% in EU cosmetic or medical-device dossiers. A serious supplier will provide a recent GC or HPLC chromatogram with a CoA for every batch.
8.5 Do menthol patches expire?
Yes. Typical shelf life is 24-36 months from manufacture when stored at 25°C/60% RH in sealed primary packaging. Menthol degrades primarily through oxidation to menthone and through volatilisation, both of which accelerate at higher temperatures. A well-formulated patch will lose no more than 5-8% of labelled menthol concentration over a 24-month shelf life; a poorly formulated one can lose 25-40%. Always ask the supplier for a 24-month real-time stability study, not just an accelerated one.
8.6 Can a menthol patch be combined with a heat patch?
No, not in the same body region at the same time. Combination use can cause unpredictable increases in skin penetration and in rare cases contact dermatitis. Sequential use is acceptable — at least 30 minutes between removing one and applying another. Within a single product line, menthol + methyl salicylate patches attempt to combine cool and warm sensations in one matrix; this is a pre-validated combination, not a user-driven combination.
8.7 Is menthol safe during pregnancy?
Topical menthol at low concentrations (1.5-3%) is generally considered safe during pregnancy, but stronger concentrations (5%+) and prolonged exposure over the abdomen or lower back are commonly advised against by clinicians. Always require a pregnant user to consult a healthcare provider before using higher-concentration menthol patches. This is the kind of warning every brand owner puts in their leaflet, and every regulator in mature markets expects to see on the inner packaging.
8.8 What is the typical skin irritation rate for menthol patches?
Pooled post-marketing data for menthol-only patches at 3-5% gives a contact dermatitis rate of about 1-2%, mostly mild and self-resolving. For menthol + methyl salicylate patches the rate rises to about 2-4%. For menthol + lidocaine patches the rate is 3-5%. Any rate above 5% is a formulation or quality issue, not a molecule issue, and the supplier should be asked to investigate the batch.
8.9 Can the same patch be reused?
No. Menthol patches are designed for single-use. The matrix releases its cooling load across the wear period and is not recharged by storage. Reuse also creates a hygiene problem (skin contact with a used matrix can introduce bacteria into the next application). Always instruct end users to discard after one wear.
8.10 What documentation should I require from a menthol patch OEM?
You should require the same 12 documents outlined in our diclofenac patch OEM reference, plus a menthol-specific GC or HPLC chromatogram with a per-batch certificate of analysis, a 24-month real-time stability dataset, and a CITES or supply-chain statement if the menthol is sourced from a natural l-menthol producer rather than a synthetic one. Kangdi provides all of these in our standard RFQ dossier.
8.11 How does menthol concentration interact with the patch size?
Concentration is w/w (weight per total matrix weight), so a 5x10 cm patch with 5% menthol and a 10x14 cm patch with 5% menthol have the same w/w concentration but the larger patch delivers roughly twice the total menthol payload to the skin. For consumers, larger patches feel "stronger" not because of higher concentration but because more cooling-active contacts the skin per hour. For B2B catalogue design, this is a cheap way to extend a single SKU family across use cases — same formula, different sizes, different positioning.
8.12 Where can I see a side-by-side wear comparison of different menthol concentrations?
Kangdi ships a 4-panel sample kit (3%, 5%, 7%, 10%) to qualified distributor and brand-owner accounts under our RFQ program. The kit contains four sealed pouches, a one-page summary card with the GC chromatograms, and a feedback form for testers to record first 30-minute, 4-hour, and 8-hour perception. Apply through the B2B inquiry form on our Contact Us page to receive one within 7-10 business days of supplier qualification.
9. About Kangdi Medical and How to Request a Sample Shipment
Henan Kangdi Medical Devices Co., Ltd has manufactured transdermal pain patches since 1989 from a GMP-certified facility in Zhoukou, Henan, China. Our menthol patch OEM programme offers private label, contract manufacturing, and bulk formats across the 1.5% to 10% concentration range, with or without combination actives like methyl salicylate, camphor, menthyl lactate, and lidocaine.
Three steps to request a sample kit. (1) Email us with your target market and the regulatory framework you intend to operate under. (2) Tell us the concentration range and combination actives you are considering. (3) We send the 4-panel kit and the supplier qualification dossier within 7-10 business days.
- Step 1: Email kangdimedical@gmail.com with "Menthol Patch Sample Kit" as the subject line.
- Step 2: Receive the supplier qualification dossier within 5 business days; sample kit ships in 7-10 business days (DHL standard).
- Step 3: Wear test internally; submit the feedback form; we will follow up with a costed quotation within 3 business days.
Tell us your target concentration, your preferred active combinations (if any), your annual volume expectation, and your home market — we will respond with a feasibility assessment, a quotation, and a sample shipment plan within 7 business days.